The multidisciplinary Seqens team provides competitive innovation to the industry by developing bio-based industrial solutions.

Enzymes / biocatalysts

Seqens creates value in bringing best-in-class expertise & knowledge in biology and chemistry tools to develop innovative and competitive bioprocesses aiming at manufacturing pharmaceuticals, cosmetics, chemicals, and phytochemicals.

We offer our customers an entry to a unique biodiversity of microorganisms (6000 strains: extremophiles, bacteria, Archaea, Fungi, microalgae…)

  • an entry to a unique biodiversity of microorganisms (6000 strains: extremophiles, bacteria, Archaea, Fungi, microalgae, and more)
  • state-of-the-art proprietary technologies for molecular engineering/assay development and screening
  • development of enzymes that can be used as biocatalysts for alternative synthetic routes
  • biocatalyst production, testing and optimization
  • integrated offer for biocatalyst application at industrial scale


microalgae

Seqens’ partner, Alganelle, provides complementary biotechnology services through Contract Research Services to develop and manufacture a wide spectrum of natural, high added value molecules from microalgae.

Our locations

Address PCAS, 70 Allée Graham Bell
30000 Nîmes
Phone +33 4 66 70 64 64
Market Pharmaceutical, Specialty Ingredients & Cosmetics
Email seqensrdnimesinfo@seqens.com
More information

Surface: 1, 000 m²

Lab surface: 500 m²

Capacities:

  • 1 kilo-lab in fermentation (80 L total capacity)
  • Robotic platform for highthroughput screening (HTS)
  • Analytical platform for chromatography (GC, GC-MS, U-HPLC)

Flagship technologies: 

  • Protein engineering
  • Microbiology aerobic & anaerobic
  • Syngas fermentation
  • Enzymes & strains fermentation
  • Biochemistry
  • Biocatalysis
  • Design of experiments (DoE)
  • Data mining

Number of scientists: 19

EcoVadis CSR Rating: Silver Certification

 

Address PCAS, ZI de Limay 2, 8 Rue de Rouen
78440 Porcheville
Phone +33 1 34 79 57 00
Market Pharmaceutical, Specialty Ingredients & Cosmetics
Email ContactSeqensPCV@seqens.com
More information

Surface: 40, 000 m²

Lab surface: 2, 000 m²

Capabilities:

  • 6 kilo-labs
  • 2 cGMP pilot plants with 11 multipurpose reactors from 100 L to 2, 800 L (total capacity of 12 m³)
  • Temperature range: -15/+150°C  (hastelloy reactor: -80/+200°C)
  • 3 finishing rooms (agitated filter dryers, filters, dryers, milling and sieving equipments)

Flagship technologies:

  • Crystallization expertise and technologiesd(salt, co-crystal and polymorph screenings, process development)
  • Process Safety expertise and tecnologies
  • Flow chemistry for fine chemicals
  • Potent API process development
  • Genotoxic Impurities
  • Issue Management
  • Generic A.P.I Solid state expertise

Last inspection: ANSM  October 2018

Certification: GMP

Number of scientists: 110

Other: Ecosystem Pharma with integrated services

Frédéric Schab Scientific committee